ELANElanco Animal Health Inc

NYSE elanco.com


$ 14.09 $ -0.06 (-0.42 %)    

Tuesday, 02-Jul-2024 14:19:42 EDT
QQQ $ 485.97 $ 6.08 (1.27 %)
DIA $ 392.45 $ 1.61 (0.41 %)
SPY $ 547.55 $ 3.81 (0.7 %)
TLT $ 90.36 $ -0.31 (-0.35 %)
GLD $ 215.18 $ -0.09 (-0.04 %)
$ 14.1
$ 14.15
$ 14.08 x 116
$ 14.09 x 200
$ 13.83 - $ 14.24
$ 8.52 - $ 18.80
6,505,828
na
6.99B
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 02-20-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-neutral-on-elanco-animal-health-lowers-price-target-to-16

Piper Sandler analyst David Westenberg maintains Elanco Animal Health (NYSE:ELAN) with a Neutral and lowers the price target...

 barclays-maintains-overweight-on-elanco-animal-health-lowers-price-target-to-21

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and lowers the price target from...

 elanco-animal-health-shares-sink-on-unexpected-label-update-for-canine-dermatology-drug

Elanco Animal Health shares drop after updates on FDA approval timelines for Zenrelia and Credelio Quattro. Zenrelia's U.S....

 piper-sandler-reiterates-neutral-on-elanco-animal-health-raises-price-target-to-19

Piper Sandler analyst David Westenberg reiterates Elanco Animal Health (NYSE:ELAN) with a Neutral and raises the price targe...

 barclays-maintains-overweight-on-elanco-animal-health-raises-price-target-to-23

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from...

 elanco-animal-healths-q1-earnings-show-improved-base-business-analyst-highlights-slightly-delayed-but-encouraging-pipeline

Elanco Animal Health (NYSE: ELAN) reports Q1 results: adjusted EPS $0.34 (-26% Y/Y), sales $1.21B (-4% Y/Y). 2024 guidance: EPS...